ASSESSMENT OF THE RELAXATION AND FEASIBILITY OF SALAZOPYRIN IN THE HANDLING OF EXTREME ALOPECIA CIRCUMSCRIPTA

Objective: To assess the relaxation and feasibility of Salazopyrin in the handling of extreme Alopecia Circumscripta.

Methods: Our current exploration was led at Jinnah Hospital, Lahore from February 2018 to January 2019. This was a valuable non-randomized, flexible first. A total of 45 subjects were evoked for appraisal. Victims were designated from the branch of the Dermatology Unit of the Jinnah Hospital, Lahore. Subjects were experimental with 500mg/day of Salazopyrin at a limit of 4 grams/day. The share for the youths was 10mg/kg/day. Victims were tracked up every two weeks. Sensitive victims were tracked for a supplementary 4 months. All significant evidence was logged and publicized.

Results: Four out of 64 victims (7%) responded to conduct. Two of these victims had a mid-response and two had a whole response. There was no important sex dissimilarity in the response to conduct. The important indication experimental was the hepatotoxicity initiate in 5 victims subsequent in interruption of the medication.

 Conclusion: Salazopyrin is supposed to be abstemiously threatened but not feasible in the conduct of dangerous AA.

Keywords: Alopecia universalis, Alopecia Circumscripta, sulphasalazine, alopecia total.